UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

First‐in‐Human Study of the Safety and Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection

American journal of transplantation, 2014-06, Vol.14 (6), p.1346-1355

2014

Volltextzugriff (PDF)

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

Transplantation proceedings, 2001-02, Vol.33 (1-2), p.1659-1660

2001

Volltextzugriff (PDF)

Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial

Transplantation, 1997-07, Vol.64 (2), p.274

1997

Volltextzugriff (PDF)

Induction immunotherapy in heart transplantation with T10B9.1A-31 : A phase I study

The Journal of heart and lung transplantation, 1997-09, Vol.16 (9), p.913-916

1997

Volltextzugriff (PDF)

Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation

Transplantation proceedings, 1995-10, Vol.27 (5 Suppl 1), p.46-46

1995

Volltextzugriff (PDF)

T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection

American journal of kidney diseases, 1989-11, Vol.14 (5 Suppl 2), p.61

1989

Volltextzugriff (PDF)

Comparison of T10B9.1A-31 and OKT3 in treating acute renal allograft rejection

Transplantation proceedings, 1993-02, Vol.25 (1), p.543-545

1993

Volltextzugriff (PDF)

Renal vein thrombosis presenting as renal mass

Urology (Ridgewood, N.J.), 1989-09, Vol.34 (3), p.164-167

1989

Volltextzugriff (PDF)

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

American journal of kidney diseases, 2003-02, Vol.41 (2), p.464-470

2003

Volltextzugriff (PDF)

Treatment of acute cellular kidney allograft rejection with T10B9.1A-31A anti T-cell monoclonal antibody

Transplantation proceedings, 1989-02, Vol.21 (1 Pt 2), p.1778-1784

1989

Volltextzugriff (PDF)

Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients

Transplantation, 1992-01, Vol.53 (1), p.80

1992

Volltextzugriff (PDF)

Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study

Transplantation, 2008-05, Vol.85 (9), p.1261

2008

Volltextzugriff (PDF)

T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action

Clinical transplantation, 1996-12, Vol.10 (6 Pt 2), p.607-613

1996

Volltextzugriff (PDF)

Treatment of acute rejection with anti-T-cell antigen receptor complex αβ (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody : results of a prospective randomized double-blind trial

Transplantation proceedings, 1991, Vol.23 (1), p.1062-1065

1991

Volltextzugriff (PDF)

Direct neural inhibition of insulin secretion in response to systemic hypoglycemia

The American journal of physiology, 1976-04, Vol.230 (4), p.1090-1094

1976

Volltextzugriff (PDF)

Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial

Transplantation proceedings, 1991-02, Vol.23 (1 Pt 2), p.1062-1065

1991

Volltextzugriff (PDF)

Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection

Transplantation proceedings, 1993-02, Vol.25 (1 Pt 1), p.543-545

1993

Volltextzugriff (PDF)

Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation

Transplantation proceedings, 1901-01, Vol.27 (5), p.46-46

1901

Volltextzugriff (PDF)

Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells

PloS one, 2017-02, Vol.12 (2), p.e0172037-e0172037

2017

Volltextzugriff (PDF)

Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor

The journal of clinical endocrinology and metabolism, 2019-09, Vol.104 (9), p.4127-4142

2019

Volltextzugriff (PDF)

Higher fish but lower micronutrient intakes: Temporal changes in fish consumption from capture fisheries and aquaculture in Bangladesh

PloS one, 2017-04, Vol.12 (4), p.e0175098-e0175098

2017

Volltextzugriff (PDF)

Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial

Kidney international, 2011-04, Vol.79 (8), p.897-907

2011

Volltextzugriff (PDF)

Naltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial

The American journal of psychiatry, 1999-11, Vol.156 (11), p.1758-1764

1999

Volltextzugriff (PDF)

CD40‐mediated signalling influences trafficking, T‐cell receptor expression, and T‐cell pathogenesis, in the NOD model of type 1 diabetes

Immunology, 2017-10, Vol.152 (2), p.243-254

2017

Volltextzugriff (PDF)

Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor

The Journal of immunology (1950), 2019-05, Vol.202 (1_Supplement), p.115-115.4

2019

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Englisch
(119)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First‐in‐Human Study of the Safety and Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial

Induction immunotherapy in heart transplantation with T10B9.1A-31 : A phase I study

Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation

T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection

Comparison of T10B9.1A-31 and OKT3 in treating acute renal allograft rejection

Renal vein thrombosis presenting as renal mass

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

Treatment of acute cellular kidney allograft rejection with T10B9.1A-31A anti T-cell monoclonal antibody

Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients

Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study

T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action

Treatment of acute rejection with anti-T-cell antigen receptor complex αβ (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody : results of a prospective randomized double-blind trial

Direct neural inhibition of insulin secretion in response to systemic hypoglycemia

Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial

Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection

Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation

Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells

Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor

Higher fish but lower micronutrient intakes: Temporal changes in fish consumption from capture fisheries and aquaculture in Bangladesh

Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial

Naltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial

CD40‐mediated signalling influences trafficking, T‐cell receptor expression, and T‐cell pathogenesis, in the NOD model of type 1 diabetes

Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor

Aktive Filter

Suchergebnisse filtern